CLPXY yields 5.29% · PFE yields 6.13%● Live data
📍 CLPXY pulled ahead of the other in Year 1
Combined, CLPXY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CLPXY + PFE for your $10,000?
China Longyuan Power Group Corporation Limited generates and sells wind and coal power in the People's Republic of China. It operates through segments, Wind Power and Coal Power. The company designs, develops, constructs, manages, and operates wind and coal power plants. It also operates other power projects, such as thermal, solar, tidal, biomass, and geothermal solar power. In addition, the company is involved in the coal trading business. Further, it manufactures and sells power equipment; provides consulting, maintenance, and training services to wind and other renewable power generation plants; and generates electric power for external power grid companies. The company was formerly known as China Longyuan Electric Power Group Corporation and changed its name to China Longyuan Power Group Corporation Limited in July 2009. The company was founded in 1993 and is headquartered in Beijing, the People's Republic of China. China Longyuan Power Group Corporation Limited operates as a subsidiary of China Energy Investment Corporation Limited.
Full CLPXY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.